354 related articles for article (PubMed ID: 17966044)
1. Effect of sinomenine on collagen-induced arthritis in mice.
Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S
Autoimmunity; 2007 Nov; 40(7):532-9. PubMed ID: 17966044
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Th1 and Th2 immune responses in mice by Sinomenine, an alkaloid extracted from the chinese medicinal plant Sinomenium acutum.
Feng H; Yamaki K; Takano H; Inoue K; Yanagisawa R; Yoshino S
Planta Med; 2006 Dec; 72(15):1383-8. PubMed ID: 17091433
[TBL] [Abstract][Full Text] [Related]
3. Effect of methotrexate on Th1 and Th2 immune responses in mice.
Yamaki K; Uchida H; Harada Y; Li X; Yanagisawa R; Takano H; Hayashi H; Taneda S; Mori Y; Yoshino S
J Pharm Pharmacol; 2003 Dec; 55(12):1661-6. PubMed ID: 14738593
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
5. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
6. Effects of the phosphodiesterase IV inhibitor rolipram on Th1 and Th2 immune responses in mice.
Yamaki K; Li X; Uchida H; Alam AH; Hossain MA; Yanagisawa R; Takano H; Taneda S; Hayashi H; Mori Y; Yoshino S
J Pharm Pharmacol; 2004 Jul; 56(7):877-82. PubMed ID: 15233866
[TBL] [Abstract][Full Text] [Related]
7. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of collagen-induced arthritis in mice by diesel exhaust particles.
Yoshino S; Sagai M
J Pharmacol Exp Ther; 1999 Aug; 290(2):524-9. PubMed ID: 10411558
[TBL] [Abstract][Full Text] [Related]
10. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.
Moon DO; Kim MO; Choi YH; Park YM; Kim GY
Int Immunopharmacol; 2010 May; 10(5):605-10. PubMed ID: 20188213
[TBL] [Abstract][Full Text] [Related]
11. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
[TBL] [Abstract][Full Text] [Related]
12. Difference in preventive effects between the phosphodiesterase iv inhibitor rolipram and anti-arthritic drugs on antigen-induced arthritis in mice.
Yamaki K; Li X; Hossain MA; Alam AH; Taneda S; Yanagisawa R; Takano H; Yoshino S
Immunol Invest; 2007; 36(2):131-45. PubMed ID: 17365015
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant effect of zinc oxide on Th2 but not Th1 immune responses in mice.
Matsumura M; Nagata M; Nakamura K; Kawai M; Baba T; Yamaki K; Yoshino S
Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):56-62. PubMed ID: 19811107
[TBL] [Abstract][Full Text] [Related]
14. Suppressive oligonucleotides protect against collagen-induced arthritis in mice.
Dong L; Ito S; Ishii KJ; Klinman DM
Arthritis Rheum; 2004 May; 50(5):1686-9. PubMed ID: 15146440
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
[TBL] [Abstract][Full Text] [Related]
16. T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis.
De Franco M; Gille-Perramant MF; Mevel JC; Couderc J
Eur J Immunol; 1995 Jan; 25(1):132-6. PubMed ID: 7843223
[TBL] [Abstract][Full Text] [Related]
17. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
Hanyecz A; Berlo SE; Szántó S; Broeren CP; Mikecz K; Glant TT
Arthritis Rheum; 2004 May; 50(5):1665-76. PubMed ID: 15146438
[TBL] [Abstract][Full Text] [Related]
18. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Chen J; Zhang XM; Xu Q
Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
[TBL] [Abstract][Full Text] [Related]
19. Induction of systemic Th1 and Th2 immune responses by oral administration of soluble antigen and diesel exhaust particles.
Yoshino S; Sagai M
Cell Immunol; 1999 Feb; 192(1):72-8. PubMed ID: 10066349
[TBL] [Abstract][Full Text] [Related]
20. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
Yoshino S
J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
